{
  "docId": "019de073-f0bf-7547-8ad6-12100ed22e83",
  "docSlug": "a88a01f7711a3a01e2c4b1dc80e80f39",
  "documentTitle": "BenevolentAI | Investor Conference Presentation Deck | 17 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 8,
  "pageCount": 17,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "peer_benchmark",
  "function": "compare_peers",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "Industry benchmarks based on Paul et al Nat Rev Drug Discov 2010.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-f0bf-7547-8ad6-12100ed22e83/8",
  "deckHref": "/decks/019de073-f0bf-7547-8ad6-12100ed22e83",
  "deckJsonHref": "/decks/019de073-f0bf-7547-8ad6-12100ed22e83.json",
  "deckAnchorHref": "/decks/019de073-f0bf-7547-8ad6-12100ed22e83#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.12,
        "x": 0.03,
        "y": 0.45
      },
      "kind": "callout",
      "text": "Deployment run for chosen disease",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0a104bfa-2dcf-4030-b5f0-bea8cfc14f10",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.12,
        "x": 0.85,
        "y": 0.45
      },
      "kind": "callout",
      "text": "Higher ROCE per $ spent on R&D",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "68644edb-0459-40bd-9d6d-c9ab2a0ff07e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.12,
        "x": 0.7,
        "y": 0.22
      },
      "kind": "image",
      "text": "Icons for Accuracy, Time, and Cost",
      "attrs": null,
      "subkind": "icon-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "47279797-3856-4c00-99c6-a4d63a6ea0aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.2,
        "x": 0.01,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Industry benchmarks based on Paul et al Nat Rev Drug Discov 2010.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f7de626-6810-49fa-ac3c-6dc631087a41",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.5,
        "x": 0.16,
        "y": 0.225
      },
      "kind": "table",
      "text": "Comparison table of accuracy, time, and cost metrics",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "85f7a5eb-972d-4116-8692-45b264ec1ba5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "How BenevolentAI’s approach compares to industry benchmarks",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "746b1610-77a2-4466-9121-fbe6baec5b20",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 8,
      "from": 5,
      "beatId": "a8c01471-1f45-4f55-a1ab-9186d382e923",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Agitate (Make it worse)",
      "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
      "evidence": "Slides 5-8 agitate the problem, showcasing the limitations of current approaches and the potential benefits of AI-enabled drug discovery.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 8,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "3a064e81-9455-49a9-95b4-cb453f8513d0",
      "evidence": "The document highlights the inefficiencies and costs associated with current pharma R&D approaches, implying the costs of inaction.",
      "position": 0,
      "objective": "What are the costs of not adopting AI-enabled drug discovery?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}